New wearable could double diabetes monitoring power

NCT ID NCT07139808

First seen Jun 27, 2026 · Last updated Aug 12, 2026 · Updated 2 times

Summary

This study is testing a new wearable device that continuously measures both glucose (sugar) and ketone levels in adults with type 1 diabetes. The device is worn for 15 days and its readings are compared to standard lab tests. The goal is to see if it is accurate and safe enough for everyday use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GK5 CGKM (continuous glucose and ketone monitoring device)
What this could lead to
If successful, this could provide a more accurate and convenient way for people with type 1 diabetes to monitor both glucose and ketone levels, potentially improving daily disease management.
What could go wrong
This is a very small, early-stage study with only 12 participants, focused on accuracy and safety rather than health outcomes. The device may not prove significantly better than existing monitors, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Henan University of Science and Technology

    RECRUITING

    Luoyang, Henan, 471003, China

  • The First Hospital of Hebei Medical University

    RECRUITING

    Shijiazhuang, Hebei, 050000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.